Table I.
Item | Remark* |
---|---|
General | |
• Stability assessment should cover all relevant conditions encountered in practice | A |
• Storage duration should be at least equal to the maximum storage period for any individual study sample | A |
• Deviation of the result for a stored sample from the reference value should not exceed 15% (chromatography) or 20% (binding assays) | S/L |
• Two concentration levels (low and high) suffice for stability assessment; stability at an over-curve level is not necessary unless scientifically called for | A |
• A single time point suffices for each stability assessment with an appropriate number of replicates | A |
• Stability results should generally not be extrapolated to other storage conditions | A |
Reference values | |
• Results for stored samples can be compared to nominal or t = 0 values | A |
• Fresh calibrators are essential for long-term stability assessment, but calibrators stored frozen suffice for other stability determinations as long as stability under frozen conditions is confirmed | A |
Transferability | |
• Stability results obtained in other laboratories can be used if storage conditions are similar and if the assessment has been performed in an acceptable way | A |
Failing results | |
• Stability results should be rejected in the case of an analytical error or failing calibration or QC results and be accepted otherwise | A |
• Stability results not meeting the criteria indicate that investigated storage conditions are unsuitable | A |
• Possible analytical outliers can be investigated by re-analysis in duplicate | A |
Bench-top, freeze/thaw and long-term frozen stability | |
• Storage and analysis conditions should mimic the situation for study samples | A |
• Frozen stability at a lower temperature is not needed if already demonstrated at a higher temperature, unless scientifically required | S |
Stock stability | |
• Stability assessment is needed for lowest and highest concentrations which will be stored in practice | A |
• Stability assessment is needed for the conditions used for long-term storage and for bench-top use | A |
• Deviation of the result for a stored sample from the reference value should not exceed 10% | S |
• Stability assessment for internal standards is only required when scientifically called for | S |
Extract stability | |
• Assessment of relative stability (against stored extracts of calibrators) suffices as long as extracts of calibrators and QCs will be stored together with study samples | S |
Whole blood stability | |
• Stability assessment is generally not necessary if stability in plasma/serum has been demonstrated under the same conditions, unless the analyte is known to behave differently in the presence of blood cells | A |
• Stability assessment can be performed by direct analysis of whole blood or by harvesting and subsequent analysis of plasma/serum | A |
Tissue stability | |
• Stability cannot be demonstrated for intact tissue, but only for tissue homogenate | A |
• Storage of study samples in the form of homogenate is recommended | A |
Endogenous analytes | |
• Stability assessment should be similar to that for xenobiotics, whenever possible | A |
• Stability should be assessed using the authentic matrix and the authentic analyte | A |
Deviating matrix types | |
• Additional stability assessment should be considered if the biological matrix in a particular study deviates considerably from a normal control matrix and if this deviation in composition is likely to impact analyte stability | A |
Incurred sample stability | |
• Stability in incurred samples should be considered in case of possible differences in stability in spiked and incurred samples | S |
QC quality control
*Relevant for small molecules (S), large molecules (L), or all types of molecules (A)